Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 39Squamous Cell Carcinoma of Head and Neck 20Lung Neoplasms 20Oropharyngeal Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Endometrial Neoplasms 6Carcinoma 6Pancreatic Neoplasms 5Mouth Neoplasms 5Colorectal Neoplasms 5Cholangiocarcinoma 5Biliary Tract Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Squamous Cell 4Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2

Interventions

Bevacizumab 3durvalumab 2atezolizumab 2Hepatectomy 2tremelimumab 1trastuzumab deruxtecan 1pembrolizumab 1Whole Genome Sequencing 1Standard of Care 1Specimen Handling 1Radionuclide Imaging 1Platinum 1Ipilimumab 1Immunotherapy 1Immunoglobulin G 1IMC-001 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Disulfides 1Diathermy 1Cisplatin 1Cell- and Tissue-Based Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Cisplatin × 30 days × Clear all
NCT05211323 2026-06-03

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
88 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡